|
Bacterial dysentery vaccination using intranasal patches
|
PI16/00071
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
86.515,00€
|
ERDF funds
|
|
Study of the immune response induced by autologous dendritic cell vaccines in breast cancer patients for the development of new therapeutic strategies.
|
PI16/01245
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
96.800,00€
|
ERDF funds
|
|
TMPRSS4: a novel biomarker and therapeutic target in poor prognosis squamous cell lung carcinoma
|
PI16/01352
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
University of Navarra
|
2016 AES PROJECTS RESEARCH
|
30-11-2016
|
98.615,00€
|
ERDF funds
|
|
Potential of in vivo gene editing using CRISPR/Cas for the treatment and modeling of primary hyperoxaluria.
|
PI16/00150
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
80.465,00€
|
ERDF funds
|
|
New experimental approaches to the diagnosis and treatment of cholangiocarcinoma.
|
PI16/01126
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
96.195,00€
|
ERDF funds
|
|
Molecular analysis of non-small cell lung carcinoma using state-of-the-art platforms for the development of prognostic profiles and new therapeutic tools.
|
PI16/01821
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
128.865,00€
|
ERDF funds
|
|
Exploiting SR-B1 for novel immunomodulatory drug development
|
PI16/00668
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
110.715,00€
|
ERDF funds
|
|
Treatment of myocardial infarction and prevention of adverse remodeling by application of anti-fibrotic growth factors and microRNAs.
|
PI16/00129
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
2016 - HEALTH research and development PROJECTS
|
30-11-2016
|
98.615,00€
|
ERDF funds
|
|
EPICA: Dual epigenetic targeting and immunotherapy to fight against cancer.
|
AC16/00041
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
TRANSCAN-2
|
30-11-2016
|
144.159,40€
|
ERDF funds
|
|
HEPAMUT: Mutated neo-antigens in hepatocellular carcinoma.
|
AC16/00065
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
TRANSCAN-2
|
30-11-2016
|
87.216,80€
|
ERDF funds
|
|
|
|
|
|
|
|
|
